`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case 1:19-md-02902-RGA Document 83 Filed 03/16/20 Page 1 of 7 PageID #: 1136
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`IN RE: SITAGLIPTIN PATENT LITIGATION
`
`MERCK SHARP & DOHME CORP.,
`
`Plaintiff,
`
`v.
`
`ALVOGEN PINE BROOK LLC F/K/A
`ALVOGEN PINE BROOK, INC., ALVOGEN
`MALTA OPERATIONS LTD.,
`
`Defendants.
`
`MERCK SHARP & DOHME CORP.,
`
`Plaintiff,
`
`v.
`
`ANCHEN PHARMACEUTICALS, INC., and
`PAR PHARMACEUTICAL, INC.,
`
`Defendants.
`
`MERCK SHARP & DOHME CORP.,
`
`v.
`
`SANDOZ INC.,
`
`Plaintiff,
`
`Defendant.
`
`MDL No. 19-2902-RGA
`
`C.A. No. 19-310-RGA
`
`C.A. No. 19-311-RGA
`
`C.A. No. 19-312-RGA
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Merck Sharp & Dohme Corp. Exhibit 2016
`Mylan Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp.
`IPR2020-00040
`Page 1
`
`
`
`
`
`
`
`
`
`
`Case 1:19-md-02902-RGA Document 83 Filed 03/16/20 Page 2 of 7 PageID #: 1137
`
`C.A. No. 19-313-RGA
`
`C.A. No. 19-314-RGA
`
`C.A. No. 19-316-RGA
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`MERCK SHARP & DOHME CORP.,
`
`Plaintiff,
`
`v.
`
`APOTEX INC., and APOTEX CORP.,
`
`Defendants.
`
`MERCK SHARP & DOHME CORP.,
`
`Plaintiff,
`
`v.
`
`ZYDUS PHARMACEUTICALS (USA) INC.
`and CADILA HEALTHCARE LTD.,
`
`Defendants.
`
`MERCK SHARP & DOHME CORP.,
`
`Plaintiff,
`
`v.
`
`MACLEODS PHARMACEUTICALS
`LIMITED, and MACLEODS PHARMA USA,
`INC.,
`
`Defendants.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`2
`
`Merck Sharp & Dohme Corp. Exhibit 2016
`Mylan Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp.
`IPR2020-00040
`Page 2
`
`
`
`Case 1:19-md-02902-RGA Document 83 Filed 03/16/20 Page 3 of 7 PageID #: 1138
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`MERCK SHARP & DOHME CORP.,
`
`Plaintiff,
`
`v.
`
`WATSON LABORATORIES, INC. et al,
`
`Defendants.
`
`MERCK SHARP & DOHME CORP.,
`
`Plaintiff,
`
`v.
`
`SUN PHARMACEUTICAL INDUSTRIES
`LTD.,
`
`Defendant.
`
`
`MERCK SHARP & DOHME CORP.,
`
`Plaintiff,
`
`v.
`
`WOCKHARDT BIO AG, and WOCKHARDT
`USA LLC,
`
`Defendants.
`
`MERCK SHARP & DOHME CORP.,
`
`Plaintiff,
`
`v.
`
`LUPIN LIMITED, and LUPIN
`PHARMACEUTICALS, INC.,
`
`Defendants.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`3
`
`C.A. No. 19-317-RGA
`
`C.A. No. 19-319-RGA
`
`C.A. No. 19-321-RGA
`
`C.A. No. 19-347-RGA
`
`Merck Sharp & Dohme Corp. Exhibit 2016
`Mylan Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp.
`IPR2020-00040
`Page 3
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case 1:19-md-02902-RGA Document 83 Filed 03/16/20 Page 4 of 7 PageID #: 1139
`
`
`
`
`
`
`
`
`
`
`
`MERCK SHARP & DOHME CORP.,
`
`Plaintiff,
`
`v.
`
`MYLAN PHARMACEUTICALS INC.
`
`Defendant.
`
`
`
`
`
`
`
`
`C.A. No. 19-1489-RGA
`
`STIPULATION AND [PROPOSED] ORDER TO AMEND SCHEDULING ORDER
`
`IT IS HEREBY STIPULATED AND AGREED by and among the parties hereto,
`
`subject to the approval of the Court, that the date for substantial completion of document
`
`production set forth in paragraph 3.b. of the Scheduling Order (D.I. 13) shall be extended from
`
`March 23, 2020 to and including April 22, 2020.
`
`No other dates set forth in the Scheduling Order shall be amended absent an order of
`
`this Court.
`
`Dated: March 16, 2020
`
`4
`
`Merck Sharp & Dohme Corp. Exhibit 2016
`Mylan Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp.
`IPR2020-00040
`Page 4
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case 1:19-md-02902-RGA Document 83 Filed 03/16/20 Page 5 of 7 PageID #: 1140
`
`McCARTER & ENGLISH, LLP
`
`/s/ Alexandra M. Joyce
`Michael P. Kelly (#2295)
`Daniel M. Silver (#4758)
`Alexandra M. Joyce (#6423)
`Renaissance Centre
`405 N. King Street, 8th Floor
`Wilmington, Delaware 19801
`(302) 984-6300
`mkelly@mccarter.com
`dsilver@mccarter.com
`ajoyce@mccarter.com
`
`Attorneys for Plaintiff
`
`
`
`MORRIS JAMES LLP
`
`/s/ Kenneth L. Dorsney
`Kenneth L. Dorsney (#3726)
`500 Delaware Avenue, Suite 1500
`Wilmington, DE 19801
`(302) 888-6800
`kdorsney@morrijames.com
`
`Attorneys for Defendant
`Mylan Pharmaceuticals
`Inc.
`
`
`
`
`
`
`
`
`
`
`HEYMAN ENERIO GATTUSO & HIRZEL
`LLP
`
`
`
`/s/ Dominick T. Gattuso
`Dominick T. Gattuso (#3630)
`Aaron M. Nelson (#5941)
`300 Delaware Avenue, Suite 200
`Wilmington, DE 19801
`(302) 472-7300
`dgattuso@hegh.law
`anelson@hegh.law
`
`Attorneys for Defendant Sandoz Inc.
`
`HEYMAN ENERIO GATTUSO & HIRZEL
`LLP
`
`
`
`/s/ Dominick T. Gattuso
`Dominick T. Gattuso (#3630)
`Aaron M. Nelson (#5941)
`300 Delaware Avenue, Suite 200
`Wilmington, DE 19801
`(302) 472-7300
`dgattuso@hegh.law
`anelson@hegh.law
`
`Attorneys for Defendants Watson
`Laboratories, Inc., and Teva Pharmaceuticals
`USA, Inc.
`
`5
`
`Merck Sharp & Dohme Corp. Exhibit 2016
`Mylan Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp.
`IPR2020-00040
`Page 5
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case 1:19-md-02902-RGA Document 83 Filed 03/16/20 Page 6 of 7 PageID #: 1141
`
`RICHARDS, LAYTON & FINGER, P.A.
`
`
`
`/s/ Renée M. Mosley
`Kelly E. Farnan (#4395)
`Renée M. Mosley (#6442)
`One Rodney Square
`920 N. King Street
`Wilmington, DE 19801
`(302) 651-7700
`farnan@rlf.com
`mosley@rlf.com
`
`Attorneys for Defendants Alvogen Pine Brook
`LLC, and Alvogen Malta Operations Ltd.
`
`PHILLIPS, GOLDMAN, MCLAUGHLIN &
`HALL, P.A.
`
`/s/ David A. Bilson
`John C. Phillips, Jr. (#110)
`David A. Bilson (#4986)
`1200 North Broom Street
`Wilmington, DE 19806
`(302) 655-4200
`jcp@pgmhlaw.com
`dab@pgmhlaw.com
`
`Attorneys for Defendants Apotex Inc.
`and Apotex Corp.
`
`
`
`
`
`RICHARDS, LAYTON & FINGER, P.A.
`
`/s/ Katharine L. Mowery
`Steven J. Fineman (#4025)
`Katharine L. Mowery (#5629)
`One Rodney Square
`920 N. King Street
`Wilmington, Delaware 19801
`(302) 651-7700
`fineman@rlf.com
`mowery@rlf.com
`
`Attorneys for Defendants Anchen
`Pharmaceuticals, Inc. and Par
`Pharmaceutical, Inc.
`
`RICHARDS, LAYTON & FINGER, P.A.
`
`
`
`
`
`
`
`
`
`/s/ Renée M. Mosley
`Kelly E. Farnan (#4395)
`Renée M. Mosley (#6442)
`One Rodney Square
`920 N. King Street
`Wilmington, DE 19801
`(302) 651-7700
`farnan@rlf.com
`mosley@rlf.com
`
`
`Attorneys for Defendants Wockhardt Bio AG
`and Wockhardt USA LLC
`
`ABRAMS & BAYLISS LLP
`
`/s/ John M. Seaman
`John M. Seaman (#3868)
`April M. Ferraro (#6152)
`20 Montchanin Road, Suite 200
`Wilmington, Delaware 19807
`(302) 778-1000
`seaman@abramsbayliss.com
`ferraro@abramsbayliss.com
`
`Attorneys for Defendants Macleods
`Pharmaceuticals Limited and Macleods
`Pharma USA, Inc.
`
`
`
`
`
`
`RICHARDS, LAYTON & FINGER, P.A.
`
`/s/ Alexandra M. Ewing
`Frederick L. Cottrell, III (#2555)
`Alexandra M. Ewing (#6407)
`One Rodney Square
`920 N. King Street
`Wilmington, DE 19801
`(302) 651-7700
`Cottrell@rlf.com
`Ewing@rlf.com
`
`Attorneys for Defendants Lupin Limited
`and Lupin Pharmaceuticals, Inc.
`6
`
`Merck Sharp & Dohme Corp. Exhibit 2016
`Mylan Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp.
`IPR2020-00040
`Page 6
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case 1:19-md-02902-RGA Document 83 Filed 03/16/20 Page 7 of 7 PageID #: 1142
`
`PHILLIPS, GOLDMAN, MCLAUGHLIN &
`HALL, P.A.
`
`YOUNG CONAWAY STARGATT &
`TAYLOR, LLP
`
`/s/ David A. Bilson
`John C. Phillips, Jr. (#110)
`David A. Bilson (#4986)
`1200 North Broom Street
`Wilmington, DE 19806
`(302) 655-4200
`jcp@pgmhlaw.com
`dab@pgmhlaw.com
`
`Attorneys for Defendants Zydus
`Pharmaceuticals (USA) Inc. and Cadila
`Healthcare Ltd.
`
`
`
`
`
`
`
`/s/ Samantha G. Wilson
`Anne Shea Gaza (#4093)
`Samantha G. Wilson
`(#5816) Rodney Square
`1000 North King Street
`Wilmington, DE 19801
`(302) 571-6600
`agaza@ycst.com
`swilson@ycst.com
`
`Attorneys for Defendant
`Sun Pharmaceutical Industries Ltd.
`
`IT IS SO ORDERED this
`
`day of
`
`, 2020.
`
`UNITED STATES DISTRICT JUDGE
`
`7
`
`Merck Sharp & Dohme Corp. Exhibit 2016
`Mylan Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp.
`IPR2020-00040
`Page 7
`
`